A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1998
10/29/1998	WO1998047491A2 Controlled release formulations using intelligent polymers
10/29/1998	WO1998047489A1 Sustained-release compositions and method for preparing same
10/29/1998	WO1998047483A1 Confectionery compositions
10/29/1998	WO1998047482A1 Throat soothing compositions
10/29/1998	WO1998047481A1 Use of 5ht3 antagonists for promoting intestinal lavage
10/29/1998	WO1998047479A1 Antioxidant and/or antielastase composition based on lupine oil
10/29/1998	WO1998047372A1 In-situ generation of zinc pyrithione
10/29/1998	WO1998047367A1 Fungicide active substance combinations
10/29/1998	WO1998047366A1 Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
10/29/1998	WO1998047365A1 Methods for reducing fibrinogen
10/29/1998	WO1998034601A3 Method for inhibiting intracellular viral replication
10/29/1998	WO1998033470A3 Substituted perylenequinones for use in photodynamic therapy
10/29/1998	WO1998025613A3 Galenic composition containing opioid antagonists
10/29/1998	WO1998020000A3 Substituted 3-benzylpyrazoles
10/29/1998	WO1998009953A3 Azinyloxy-and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed eta/etb endothelin receptor antagonists
10/29/1998	CA2846948A1 Fungicidal active compound combinations
10/29/1998	CA2800471A1 Fungicidal active compound combinations
10/29/1998	CA2297176A1 Substituted imidazoles useful in the treatment of inflammatory diseases
10/29/1998	CA2288292A1 Embolus therapy using insoluble microparticles or vesicles containing contrast agents
10/29/1998	CA2288272A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
10/29/1998	CA2288172A1 A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity
10/29/1998	CA2288070A1 Stabilized tibolone compositions
10/29/1998	CA2287887A1 The use of .alpha.-methyl-p-tyrosine to inhibit melanin production in iris melanocytes
10/29/1998	CA2287566A1 9,10-diazatricyclo¬4.2.1.12,5\|decane and 9,10-diazatricyclo¬3.3.1.12,6\|decane derivatives having analgesic activity
10/29/1998	CA2287508A1 Materials and methods for ribozyme treatment of retinal diseases
10/29/1998	CA2287501A1 Ibuprofen thioesters as inhibitors of nf-kb-dependent pain and inflammation mediator formation
10/29/1998	CA2287495A1 Materials and methods for treatment of retinal diseases
10/29/1998	CA2287487A1 Use of nk-1 receptor antagonists for treating eating disorders
10/29/1998	CA2287445A1 Arylsecocholadiene derivatives
10/29/1998	CA2287429A1 In-situ generation of zinc pyrithione
10/29/1998	CA2287397A1 Use of an nk-1 receptor antagonist and an ssri for treating obesity
10/29/1998	CA2287314A1 Rnase l activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies
10/29/1998	CA2287255A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/29/1998	CA2287196A1 Methods for reducing fibrinogen
10/29/1998	CA2287162A1 Neuroprotective compounds and uses thereof
10/29/1998	CA2286681A1 Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
10/29/1998	CA2286673A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
10/29/1998	CA2286607A1 Alkyl, alkenyl and alkynyl chrysamine g derivatives for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition
10/29/1998	CA2286252A1 Retinoid-like compounds
10/29/1998	CA2286120A1 Preventives or remedies for diseases affecting excessive proliferation of retinal pigment epithelial cells
10/29/1998	CA2286108A1 Process and intermediates for the preparation of 4'-trifluoromethyl-biphenyl-2-carboxylic acid (1,2,3,4-tetrahydro-isoquinolin-6-yl)-amide
10/29/1998	CA2286106A1 5-aryl-3-(8-azabicyclo(3.2.1)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/29/1998	CA2286081A1 Gastric-retained pharmaceutical composition
10/29/1998	CA2285424A1 Substituted phenyl derivatives, their preparation and use
10/29/1998	CA2285094A1 Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds
10/29/1998	CA2284729A1 Neoglycoproteins
10/29/1998	CA2272292A1 Crf antagonistic thiophenopyridines
10/29/1998	CA2258800A1 Antioxidant and/or antielastase composition based on lupine oil
10/29/1998	CA2236131A1 Emulsion preconcentrate comprising a cyclosporin propylene carbonate and glycerides
10/28/1998	EP0874050A2 Integrin ligand ITGL-TSP
10/28/1998	EP0873993A1 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
10/28/1998	EP0873992A1 Indene compounds having activity as SERMs
10/28/1998	EP0873754A1 Amino acid compositions
10/28/1998	EP0873753A1 Use of NK-1 receptor antagonists for the manufacture of a medicament in the treatment of symptoms of irritable bowel syndrome
10/28/1998	EP0873519A1 Hiv protease inhibitors
10/28/1998	EP0873424A1 Metastasis inducing dna's
10/28/1998	EP0873414A1 Galactopyranosides and their use
10/28/1998	EP0873408A1 Calcium binding proteolipid compositions and methods
10/28/1998	EP0873406A2 Protein induced by deprenyl
10/28/1998	EP0873404A1 Angiotensin converting enzyme inhibitors
10/28/1998	EP0873362A1 PROCESS FOR ISOLATING IgG AND IgA
10/28/1998	EP0873361A2 Nuclear receptor ligands and ligand binding domains
10/28/1998	EP0873357A2 Antithrombotic agents and methods of use
10/28/1998	EP0873356A1 Novel dipeptide amidines as thrombin inhibitors
10/28/1998	EP0873355A1 Tethered prodrugs by virtue of covalent linkage with analogs of glutathione
10/28/1998	EP0873351A1 Novel steroid nitrite/nitrate ester derivatives useful as anti-inflammatory drugs
10/28/1998	EP0873347A2 Novel amine derivatives of epipodophyllotoxin 2", 3"-dideoxyglycosides, preparation method therefor and use thereof as a drug and for treating cancer
10/28/1998	EP0873345A1 Preparation of glucosaminyl muramic acid derivatives
10/28/1998	EP0873341A1 Epothilone derivatives, preparation and use
10/28/1998	EP0873340A1 Heterocyclic substituted cyclopentane compounds
10/28/1998	EP0873339A1 Purine and guanine derivatives as pnp inhibitors
10/28/1998	EP0873338A1 Quinoline derivatives as type iv phosphodiesterase inhibitors
10/28/1998	EP0873337A1 Salts of n-(4-oxo-2-(1h-tetrazoyl-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutoxy)benzamide
10/28/1998	EP0873336A1 Antagonists of gonadotropin releasing hormone
10/28/1998	EP0873335A1 HETEROCYCLYL-CONDENSED BENZOYLGUANIDINES, THEIR PRODUCTION AND USE AS INHIBITORS OF THE CELLULAR Na+/H+-ANTIPORTER
10/28/1998	EP0873332A1 Discodermolide compounds and pharmaceutical compositions containing them for cancer therapy
10/28/1998	EP0873331A1 Benzofuran carboxamides and sulphonamides
10/28/1998	EP0873330A1 Diarylalkenylamine derivatives
10/28/1998	EP0873329A1 Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
10/28/1998	EP0873322A1 Novel compounds with analgesic effect
10/28/1998	EP0873321A1 Novel amido quinoxaline diones, their production and use
10/28/1998	EP0873320A1 Piperazine derivatives as tachykinin antagonists
10/28/1998	EP0873319A1 Quinazoline derivatives
10/28/1998	EP0873317A1 Pyrimidin derivatives
10/28/1998	EP0873315A1 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives
10/28/1998	EP0873312A1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors
10/28/1998	EP0873311A1 Tri-aryl ethane derivatives as pde iv inhibitors
10/28/1998	EP0873310A1 Diphenyl pyridyl ethane derivatives as pde iv inhibitors
10/28/1998	EP0873309A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
10/28/1998	EP0873308A1 O-carbamoyl-phenylalaninol compounds, their pharmaceutically useful salts and process for preparing the same
10/28/1998	EP0873304A1 Metalloproteinase inhibitors
10/28/1998	EP0873301A1 Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity
10/28/1998	EP0873295A1 Dimer-selective rxr modulators and methods for their use
10/28/1998	EP0873140A2 Immunoconjugate for the treatment of aids
10/28/1998	EP0873139A1 Antibodies with reduced net positive charge
10/28/1998	EP0873136A2 High fluorescence specific immune enhancing factor and methods of use for same
10/28/1998	EP0873134A1 Aqueous prolonged release formulation
10/28/1998	EP0873131A1 Vasodilating composition
10/28/1998	EP0873130A2 Compositions comprising pvp having an average molecular weight in the range of 3.000 to 14.000 daltons
10/28/1998	EP0873129A1 Anion exchange resin-containing tablets

1 ... 6588 6589 6590 6591 6592 6593 6594 6595 6596 6597 6598 6599 6600 6601 6602 6603 6604 6605 6606 6607 6608 ... 7860